Prostate cancer recurrence in patients with negative or equivocal conventional imaging: A role for 18F-fluciclovine-PET/CT in delineating sites of recurrence and identifying patients with oligometastatic disease.
CONCLUSION: Even at low PSA levels, 18F-fluciclovine-PET/CT identified a diverse pattern of recurrence missed with conventional imaging. One-quarter of men had oligometastatic disease, raising the potential for 18F-fluciclovine-PET/CT to guide targeted treatment of oligometastases.
PMID: 33160848 [PubMed - as supplied by publisher]
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Kim EH, Siegel BA, Teoh EJ, Andriole GL, LOCATE Study Group Tags: Urol Oncol Source Type: research
More News: Cancer | Cancer & Oncology | PET Scan | Prostate Cancer | Prostatectomy | Study | Urology & Nephrology